Hippocratic AI Secures $126M Series C Funding at $3.5B Valuation

Why It Matters

The large raise and $3.5 billion valuation underscore growing market belief that safety‑first AI can transform healthcare delivery, positioning Hippocratic AI to accelerate adoption across providers. It also signals heightened investor appetite for regulated, high‑impact AI applications in the health sector.

Deal Summary

Palo Alto‑based Hippocratic AI announced a $126 million Series C round, valuing the safety‑focused generative AI healthcare platform at $3.5 billion. The round was led by Avenir Growth with participation from CapitalG, General Catalyst, Andreessen Horowitz, Kleiner Perkins, Premji Invest, Universal Health Services and Cincinnati Children’s Hospital Medical Center.